Click for best price
Solid Formulations Drug Delivery Market Size, Share 2023
Solid Formulations are a solid body drug delivery system of various weights and shapes, adapted for introduction into orifices of the human body.4 The external membrane of the suppository will typically melt, soften, or dissolve at body temperature which allows the active ingredient to then be absorbed by the surrounding tissue. Suppository bases usually employed are cocoa butter, glycerinated gelatin, hydrogenated vegetable oils, mixtures of polyethylene glycols of various molecular weights, and fatty acid esters of polyethylene glycol. The suppository base employed has a marked influence on the release of the active ingredient incorporated in it.
This report aims to provide a comprehensive presentation of the global market for Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Formulations Drug Delivery. This report contains market size and forecasts of Solid Formulations Drug Delivery in global, including the following market information:
Global Solid Formulations Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Solid Formulations Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Powders Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Solid Formulations Drug Delivery include Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma, Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Solid Formulations Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Powders
Suppositories
Global Solid Formulations Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
Global Solid Formulations Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Solid Formulations Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Solid Formulations Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Solid Formulations Drug Delivery, market overview.
Chapter 2: Global Solid Formulations Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Solid Formulations Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Solid Formulations Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Solid Formulations Drug Delivery Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Solid Formulations Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Solid Formulations Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Solid Formulations Drug Delivery Overall Market Size
2.1 Global Solid Formulations Drug Delivery Market Size: 2022 VS 2029
2.2 Global Solid Formulations Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Solid Formulations Drug Delivery Players in Global Market
3.2 Top Global Solid Formulations Drug Delivery Companies Ranked by Revenue
3.3 Global Solid Formulations Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Solid Formulations Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Solid Formulations Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Solid Formulations Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Solid Formulations Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Solid Formulations Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Solid Formulations Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Powders
4.1.3 Suppositories
4.2 By Type - Global Solid Formulations Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Solid Formulations Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Solid Formulations Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Solid Formulations Drug Delivery Market Size, 2022 & 2029
5.1.2 Home Care Settings
5.1.3 Hospitals & Clinics
5.1.4 Burn Centers
5.1.5 Other Facilities
5.2 By Application - Global Solid Formulations Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Solid Formulations Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Solid Formulations Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Solid Formulations Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Solid Formulations Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Solid Formulations Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Solid Formulations Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Solid Formulations Drug Delivery Revenue, 2018-2029
6.3.2 US Solid Formulations Drug Delivery Market Size, 2018-2029
6.3.3 Canada Solid Formulations Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Solid Formulations Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Solid Formulations Drug Delivery Revenue, 2018-2029
6.4.2 Germany Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.3 France Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.5 Italy Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.6 Russia Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Solid Formulations Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Solid Formulations Drug Delivery Revenue, 2018-2029
6.5.2 China Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.3 Japan Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.6 India Solid Formulations Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Solid Formulations Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Solid Formulations Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Solid Formulations Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Solid Formulations Drug Delivery Market Size, 2018-2029
6.7.3 Israel Solid Formulations Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Solid Formulations Drug Delivery Market Size, 2018-2029
6.7.5 UAE Solid Formulations Drug Delivery Market Size, 2018-2029
7 Solid Formulations Drug Delivery Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Solid Formulations Drug Delivery Major Product Offerings
7.1.4 Pfizer Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Company Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Solid Formulations Drug Delivery Major Product Offerings
7.2.4 Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceuticals Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb Solid Formulations Drug Delivery Major Product Offerings
7.3.4 Bristol Myers Squibb Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Lead Chemical
7.4.1 Lead Chemical Company Summary
7.4.2 Lead Chemical Business Overview
7.4.3 Lead Chemical Solid Formulations Drug Delivery Major Product Offerings
7.4.4 Lead Chemical Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Lead Chemical Key News & Latest Developments
7.5 Purdue Pharma
7.5.1 Purdue Pharma Company Summary
7.5.2 Purdue Pharma Business Overview
7.5.3 Purdue Pharma Solid Formulations Drug Delivery Major Product Offerings
7.5.4 Purdue Pharma Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Purdue Pharma Key News & Latest Developments
7.6 Glenmark Pharmaceuticals
7.6.1 Glenmark Pharmaceuticals Company Summary
7.6.2 Glenmark Pharmaceuticals Business Overview
7.6.3 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Major Product Offerings
7.6.4 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.7 Galderma
7.7.1 Galderma Company Summary
7.7.2 Galderma Business Overview
7.7.3 Galderma Solid Formulations Drug Delivery Major Product Offerings
7.7.4 Galderma Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Galderma Key News & Latest Developments
7.8 Johnson & Johnson Private
7.8.1 Johnson & Johnson Private Company Summary
7.8.2 Johnson & Johnson Private Business Overview
7.8.3 Johnson & Johnson Private Solid Formulations Drug Delivery Major Product Offerings
7.8.4 Johnson & Johnson Private Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Private Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Solid Formulations Drug Delivery Major Product Offerings
7.9.4 GlaxoSmithKline Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Bausch Health Companies
7.10.1 Bausch Health Companies Company Summary
7.10.2 Bausch Health Companies Business Overview
7.10.3 Bausch Health Companies Solid Formulations Drug Delivery Major Product Offerings
7.10.4 Bausch Health Companies Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Bausch Health Companies Key News & Latest Developments
7.11 Hisamitsu Pharmaceuticals
7.11.1 Hisamitsu Pharmaceuticals Company Summary
7.11.2 Hisamitsu Pharmaceuticals Business Overview
7.11.3 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Major Product Offerings
7.11.4 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Hisamitsu Pharmaceuticals Key News & Latest Developments
7.12 Cipla
7.12.1 Cipla Company Summary
7.12.2 Cipla Business Overview
7.12.3 Cipla Solid Formulations Drug Delivery Major Product Offerings
7.12.4 Cipla Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.12.5 Cipla Key News & Latest Developments
7.13 Bayer
7.13.1 Bayer Company Summary
7.13.2 Bayer Business Overview
7.13.3 Bayer Solid Formulations Drug Delivery Major Product Offerings
7.13.4 Bayer Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.13.5 Bayer Key News & Latest Developments
7.14 Viatris
7.14.1 Viatris Company Summary
7.14.2 Viatris Business Overview
7.14.3 Viatris Solid Formulations Drug Delivery Major Product Offerings
7.14.4 Viatris Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.14.5 Viatris Key News & Latest Developments
7.15 3M
7.15.1 3M Company Summary
7.15.2 3M Business Overview
7.15.3 3M Solid Formulations Drug Delivery Major Product Offerings
7.15.4 3M Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.15.5 3M Key News & Latest Developments
7.16 Merck & Co
7.16.1 Merck & Co Company Summary
7.16.2 Merck & Co Business Overview
7.16.3 Merck & Co Solid Formulations Drug Delivery Major Product Offerings
7.16.4 Merck & Co Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.16.5 Merck & Co Key News & Latest Developments
7.17 Crescita Therpeautics
7.17.1 Crescita Therpeautics Company Summary
7.17.2 Crescita Therpeautics Business Overview
7.17.3 Crescita Therpeautics Solid Formulations Drug Delivery Major Product Offerings
7.17.4 Crescita Therpeautics Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.17.5 Crescita Therpeautics Key News & Latest Developments
7.18 Novartis International
7.18.1 Novartis International Company Summary
7.18.2 Novartis International Business Overview
7.18.3 Novartis International Solid Formulations Drug Delivery Major Product Offerings
7.18.4 Novartis International Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.18.5 Novartis International Key News & Latest Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Solid Formulations Drug Delivery Major Product Offerings
7.19.4 Boehringer Ingelheim Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.19.5 Boehringer Ingelheim Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Solid Formulations Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Solid Formulations Drug Delivery Market Drivers in Global Market
Table 3. Solid Formulations Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Solid Formulations Drug Delivery in Global Market
Table 5. Top Solid Formulations Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Solid Formulations Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Solid Formulations Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Solid Formulations Drug Delivery Product Type
Table 9. List of Global Tier 1 Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Solid Formulations Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Solid Formulations Drug Delivery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Solid Formulations Drug Delivery Product Offerings
Table 32. Pfizer Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Teva Pharmaceuticals Company Summary
Table 35. Teva Pharmaceuticals Solid Formulations Drug Delivery Product Offerings
Table 36. Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceuticals Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb Solid Formulations Drug Delivery Product Offerings
Table 40. Bristol Myers Squibb Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. Lead Chemical Company Summary
Table 43. Lead Chemical Solid Formulations Drug Delivery Product Offerings
Table 44. Lead Chemical Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Lead Chemical Key News & Latest Developments
Table 46. Purdue Pharma Company Summary
Table 47. Purdue Pharma Solid Formulations Drug Delivery Product Offerings
Table 48. Purdue Pharma Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Purdue Pharma Key News & Latest Developments
Table 50. Glenmark Pharmaceuticals Company Summary
Table 51. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Product Offerings
Table 52. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Glenmark Pharmaceuticals Key News & Latest Developments
Table 54. Galderma Company Summary
Table 55. Galderma Solid Formulations Drug Delivery Product Offerings
Table 56. Galderma Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Galderma Key News & Latest Developments
Table 58. Johnson & Johnson Private Company Summary
Table 59. Johnson & Johnson Private Solid Formulations Drug Delivery Product Offerings
Table 60. Johnson & Johnson Private Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Private Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Solid Formulations Drug Delivery Product Offerings
Table 64. GlaxoSmithKline Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Bausch Health Companies Company Summary
Table 67. Bausch Health Companies Solid Formulations Drug Delivery Product Offerings
Table 68. Bausch Health Companies Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Bausch Health Companies Key News & Latest Developments
Table 70. Hisamitsu Pharmaceuticals Company Summary
Table 71. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Product Offerings
Table 72. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Hisamitsu Pharmaceuticals Key News & Latest Developments
Table 74. Cipla Company Summary
Table 75. Cipla Solid Formulations Drug Delivery Product Offerings
Table 76. Cipla Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 77. Cipla Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Solid Formulations Drug Delivery Product Offerings
Table 80. Bayer Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 81. Bayer Key News & Latest Developments
Table 82. Viatris Company Summary
Table 83. Viatris Solid Formulations Drug Delivery Product Offerings
Table 84. Viatris Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 85. Viatris Key News & Latest Developments
Table 86. 3M Company Summary
Table 87. 3M Solid Formulations Drug Delivery Product Offerings
Table 88. 3M Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 89. 3M Key News & Latest Developments
Table 90. Merck & Co Company Summary
Table 91. Merck & Co Solid Formulations Drug Delivery Product Offerings
Table 92. Merck & Co Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 93. Merck & Co Key News & Latest Developments
Table 94. Crescita Therpeautics Company Summary
Table 95. Crescita Therpeautics Solid Formulations Drug Delivery Product Offerings
Table 96. Crescita Therpeautics Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 97. Crescita Therpeautics Key News & Latest Developments
Table 98. Novartis International Company Summary
Table 99. Novartis International Solid Formulations Drug Delivery Product Offerings
Table 100. Novartis International Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 101. Novartis International Key News & Latest Developments
Table 102. Boehringer Ingelheim Company Summary
Table 103. Boehringer Ingelheim Solid Formulations Drug Delivery Product Offerings
Table 104. Boehringer Ingelheim Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 105. Boehringer Ingelheim Key News & Latest Developments
List of Figures
Figure 1. Solid Formulations Drug Delivery Segment by Type in 2022
Figure 2. Solid Formulations Drug Delivery Segment by Application in 2022
Figure 3. Global Solid Formulations Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Solid Formulations Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Solid Formulations Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Solid Formulations Drug Delivery Revenue in 2022
Figure 8. By Type - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 16. US Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 20. Germany Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 21. France Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 28. China Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. India Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 34. Brazil Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 37. Turkey Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Lead Chemical Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Purdue Pharma Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Galderma Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Private Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bausch Health Companies Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Cipla Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bayer Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Viatris Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. 3M Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Merck & Co Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Crescita Therpeautics Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Novartis International Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Boehringer Ingelheim Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
